Art-No.: A-753
Date: 15/17 October 2019
Price: EUR 380,-
No. | Topic | Summary | Pages |
9782 | A first Case Study: how things can go wrong | 0 | 10 |
9783 | Interface between GMP and GCP | 0 | 14 |
9784 | CTS Planning | 0 | 31 |
9785 | Workshop on Study Planning: Challenges from a CTS coordinators perspective | 0 | 6 |
9786 | Packaging and Labelling of IMPs | 0 | 45 |
9788 | A last case study - how things can go wrong | 0 | 9 |
9789 | Distribution of IMP Supplies | 0 | 46 |
11121 | Challenges in the initiation and conduct of Compassionate Use | 0 | 15 |
11643 | The Role of the QP in Clinical Trials | 0 | 16 |
11644 | Handling IMPs at a Hospital Pharmacy | 0 | 40 |
11645 | Workshop on GCP Aspects: Handling IMPs at the Investigator's Site | 0 | 3 |
11646 | Contracts and Agreements | 0 | 55 |
12945 | Workshop on Case Studies: Open discussion of QP tasks and challenges in Clinical Trials | 0 | 15 |
12946 | GCP Aspects to Consider for IMPs | 0 | 65 |
12947 | GCP / GMP Inspections | 0 | 33 |
14761 | Changes in the regulatory Landscape of Clinical Trials | 0 | 53 |